Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup Inc. generates news primarily around quarterly earnings announcements, acquisition activity, product innovations in pharmaceutical drug delivery, and sustainability initiatives. The company's news flow reflects its position as a global packaging and dispensing systems manufacturer serving pharmaceutical, beauty, and consumer markets.
Earnings reports provide insight into performance across AptarGroup's three business segments: Beauty and Home (cosmetic and household product dispensers), Pharma (drug delivery devices and injectable components), and Food and Beverage (closure systems). These reports often highlight regional demand trends, raw material cost impacts, and customer order patterns across different end markets. Pharmaceutical segment news frequently involves regulatory approvals for new drug delivery devices, such as FDA clearances for inhaler systems or nasal spray platforms, which can signal future revenue opportunities as pharmaceutical customers integrate these devices into their products.
Acquisition announcements reveal AptarGroup's strategy for expanding technical capabilities or entering new market niches within the dispensing systems industry. The company periodically acquires specialized manufacturers to broaden its product portfolio or strengthen its presence in high-growth areas like digital health technologies and sustainable packaging solutions. News about dividend actions reflects the company's capital allocation priorities and cash flow generation capacity.
Conference presentation announcements indicate when AptarGroup executives discuss business strategy and market outlook with institutional investors, providing opportunities to understand management's perspective on industry dynamics. Material events filed with the SEC can include significant contracts, facility expansions, or changes in business operations that affect shareholder interests.
AptarGroup (NYSE: ATR) announces a partnership with CARE® to support global health initiatives, including the Fast + Fair COVID-19 Vaccine Response Campaign. This initiative aims to ensure equitable vaccine access for over 100 million people, focusing on women, impoverished communities, and healthcare workers across 10 countries. Aptar’s sponsorship emphasizes its commitment to diversity, inclusion, and women's empowerment, while aligning with its business model of producing vaccine delivery components. The collaboration promises to enhance CARE's efforts in advocating for equitable health policies worldwide.
AptarGroup, Inc. (NYSE: ATR) has announced that its Activ-Film™ technology will protect a new SARS Rapid Antigen test for COVID-19, recently granted Emergency Use Authorization (EUA) by the FDA. This QuickVue® SARS Antigen test, developed by Quidel® Corporation, delivers results in just 10 minutes, enhancing access to affordable COVID-19 testing, especially in schools and rural areas. Activ-Film™ integrates material science to ensure test accuracy by protecting against moisture and environmental factors. Aptar is dedicated to providing critical healthcare solutions during the pandemic.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, payable on February 17, 2021, to stockholders of record as of January 27, 2021. The company will also hold a conference call on February 19, 2021, at 8:00 a.m. Central Time to discuss its fourth quarter and year-end results for 2020. Additionally, the 2021 Annual Meeting of Stockholders will be held virtually on May 5, 2021, at 9:00 a.m. Central Time, with a record date for voting set for March 12, 2021.
AptarGroup, Inc. (NYSE: ATR) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, with a virtual presentation at 2:50 p.m. (EST) by key executives including President and CEO Stephan Tanda. A live webcast will be available in the Investors section of the Aptar website and a replay will be accessible for 90 days post-event. Aptar is a global leader in drug delivery and packaging solutions, headquartered in Crystal Lake, Illinois, employing 14,000 people across 19 countries.
AptarGroup, Inc. (NYSE: ATR) has announced the schedule for its quarterly conference calls for 2021. Key dates include:
- 4th Quarter and Annual Results: February 18, 2021 (Call on February 19, 2021, at 8:00 a.m. CT)
- 1st Quarter 2021 Results: April 29, 2021 (Call on April 30, 2021, at 8:00 a.m. CT)
- 2nd Quarter 2021 Results: July 29, 2021 (Call on July 30, 2021, at 8:00 a.m. CT)
- 3rd Quarter 2021 Results: October 28, 2021 (Call on October 29, 2021, at 8:00 a.m. CT)
Press releases will be issued after the close of trading on NYSE.
AptarGroup, Inc. (NYSE:ATR) reported a strong third quarter for 2020, with sales increasing by 8% to $759 million, driven by currency effects and recent acquisitions. The Pharma segment saw core sales growth of 11%, while Beauty + Home and Food + Beverage segments experienced slower growth, impacted by COVID-19. Reported earnings per share rose 12% to $0.95. Year-to-date sales were stable at $2.18 billion. The company anticipates continued core sales growth in Q4, expecting EPS between $0.84 and $0.92. A quarterly dividend of $0.36 per share was declared, payable November 18, 2020.
FAQ
What is the current stock price of Aptargroup (ATR)?
What is the market cap of Aptargroup (ATR)?
